Selective aggregation of endogenous β-amyloid peptide and soluble amyloid precursor protein in cerebrospinal fluid by zinc

Journal of Neurochemistry

Volumn 69, Issue 3, 1997, Pages 1204-1212

  Brown, Abraham M ^a,b   Tummolo, Donna M ^a   Rhodes, Kenneth J ^a   Hofmann, John R ^a   Jacobsen, J Steven ^a   Sonnenberg Reines, June ^a  

^a PFIZER INC   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Aggregation; Alzheimer's disease; Amyloid deposit; Brain; Cerebrospinal fluid; Zinc; Amyloid peptide

Indexed keywords

AMYLOID BETA PROTEIN; ZINC;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BIREFRINGENCE; CEREBROSPINAL FLUID ANALYSIS; DOG; ENZYME LINKED IMMUNOSORBENT ASSAY; NEUROTOXICITY; NONHUMAN; PEPTIDE SYNTHESIS; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; ULTRACENTRIFUGATION;

ANIMALIA; CANIS FAMILIARIS;

EID: 0030757388     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69031204.x     Document Type: Article

References (76)

1. Abraham C. R., Shirahama T., and Potter H. (1990) Alpha 1-antichymotrypsin is associated solely with amyloid deposits containing the beta-protein. Amyloid and cell localization of alpha 1-antichymotrypsin. Neurobiol. Aging 11, 123-129.
2. 2+ from brain tissue during activity. Nature 308, 734-736.
3. Barrow C. J., Yasuda A., Kenny P. T., and Zagorski M. G. (1992) Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease: analysis of circular dichroism spectra. J. Mol. Biol. 225, 1075-1093.
4. Biere A. J., Ostaszewski B., Stimson E. R., Hyman B. T., Maggio J. E., and Selkoe D. J. (1996) Amyloid β-peptide is transported on lipoproteins and albumin in human plasma. J. Biol. Chem. 271, 32916-32922.
5. Brown A. M., Tummolo D. M., Spruyt M. A., Jacobsen J. S., and Sonnenberg-Reines J. L. (1996) Evaluation of cathepsins D and G and EC 3.4.24.15 as candidate β-secretase proteases using peptide and amyloid precursor protein substrates. J. Neurochem. 66, 2436-2445.
6. Burdick D., Soreghan B., Kwon M., Kosmoski J., Knauer M., Henschen A., Yates J., Cotman C., and Glabe C. (1992) Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J. Biol. Chem. 267, 546-554.
7. Bush A. I., Multhaup G., Moir R. D., Williamson T. G., Small D. H., Rumble B., Pollwein P., Beyreuther K., and Masters C. L. (1993) A novel zinc (II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer's disease. J. Biol. Chem. 268, 16109-16112.
8. Bush A. I., Pettingell W. H., Multhaup G., Paradis M., Vonsattel J. P., Gussella J. F., Beyreuther K., Masters C. L., and Tanzi R. E. (1994) Rapid induction of Alzheimer A-beta amyloid formation by zinc. Science 265, 1464-1467.
9. Castano E. M., Prelli F., Wisniewski T., Golabek A., Kumar R. A., Soto C., and Frangione B. (1995) Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E. Biochem J. 306, 599-604.
10. Clements A., Allsop D., Walsh D. M., and Williams C. H. (1996) Aggregation and metal-binding properties of mutant forms of amyloid Aβ peptide of Alzheimer's disease. J. Neurochem. 66, 740-747.
11. Cummings B. J., Su J. H., Cotman C. W., White R., and Russel M. J. (1993) β-Amyloid accumulation in aged canine brain: a model of early plaque formation in Alzheimer's disease. Neurobiol. Aging 14, 547-560.
12. Cummings B. J., Head E., Afagh A. J., Milgram A. W., and Cotman C. W. (1996) β-Amyloid accumulation correlates with cognitive dysfunction in the aged canine. Neurobiol. Learn. Mem. 66, 11-23.
13. Danscher G., Howell G. A., Perez-Clausell J., and Hertel N. (1985) The dithizone, Timm's sulphide silver and the selenium methods demonstrate a chelatable pool of zinc in CNS. A proton activation (PIXE) analysis of carbon tetrachloride extracts from rat brains and spinal cords intravitally treated with dithizone. Histochemistry 83, 419-422.
14. Dawson R. M. C., Elliot D. C., Elliot W. H., and Jones K. M. (1986) Data for Biochemical Research. Clarendon Press, Oxford.
15. El-Agnaf O. M. A., Irvine G. B., and Guthrie D. J. S. (1997) Conformations of β-amyloid in solution. J. Neurochem. 68, 437-438.
16. Esler W. P., Stimson E. R., Jennings J. M., Ghilardi J. R., Mantyh P. W., and Maggio J. E. (1996) Zinc-induced aggregation of human and rat β-amyloid peptides in vitro. J. Neurochem. 66, 723-732.
17. Fraser P. E., Nguyen J. T., Surewicz W. K., and Kirschner D. A. (1991) pH-dependent structural transitions of Alzheimer amyloid peptides. Biophys. J. 60, 1190-1201.
18. Frautschy S. A., Baird A., and Cole G. M. (1991) Effects of injected Alzheimer beta-amyloid cores in rat brain. Proc. Natl. Acad. Sci. USA 88, 8362-8366.
19. Frederickson C. J. (1989) Neurobiology of zinc-containing neurons. Int. Rev. Neurobiol. 31, 145-238.
20. Ghiso J., Matsubara E., Koudinov A., Choi-Miura N. H., Tomita M., Wisniewski T., and Frangione B. (1993) The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex. Biochem. J. 293, 27-30.
21. Glenner G. G. and Wong C. W. (1984) Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 120, 885-890.
22. Glenner G. G., Eanes E. D., and Page D. L. (1972) Infrared spectroscopy of human amyloid fibrils and immunoglobulin proteins. J. Histochem. Cytochem. 20, 821-826.
23. Gravina S. A., Ho L., Eckman C. B., Long K. E., Otvos L., Younkin L. H., Suzuki N., and Younkin S. G. (1995) Amyloid β protein (Aβ) in Alzheimer's disease brain. J. Biol. Chem. 270, 7013-7016.
24. Hershey C. O., Hershey L. A., Varnes A., Vibhakar S. D., Lavin P., and Strain H. (1983) Cerebrospinal fluid trace element content in dementia: clinical, radiologic, and pathologic correlations. Neurology 33, 1350-1353.
25. Hilbich C., Kisters-Woike B., Reed J., Masters C. L., and Beyreuther K. (1991) Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides. J. Mol Biol. 218, 149-163.
26. Howell G. A., Welch M., and Frederickson C. J. (1984) Stimulation-induced uptake and release of zinc in hippocampal slices. Nature 308, 736-738.
27. Johnstone E. M., Chancy M. O., Norris F. H., Pascual R., and Little S. P. (1991) Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis. Mol. Brain Res. 10, 299-305.
28. Kaneko I., Yamada N., Sakuraba Y., Kamenosono M., and Tutumi S. (1995) Suppression of mitochondrial succinate dehydrogenase, a primary target of β-amyloid, and its derivative racemized at Ser residue. J. Neurochem. 65, 2585-2593.
29. Kim K. S., Wen G. Y., Bancher C., Chen C. M. J., Sapienza V. J., and Wisniewski H. M. (1990) Detection and quantitation of amyloid β-peptide with 2 monoclonal antibodies. Neurosci. Res. Commun. 7, 113-122.
30. Koh J. Y., Suh S. W., Gwag B. J., He Y. Y., Hsu C. Y., and Choi D. W. (1996) The role of zinc in selective neuronal death after transient global cerebral ischemia. Science 272, 1013-1016.
31. Kowall N. W., Beal M. F., Busciglio J., Duffy L. K., and Yankner B. A. (1991) An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P. Proc. Natl. Acad. Sci. USA 88, 7247-7251.
32. 2+ to natural mutants of serum albumin and proalbumin. Biochem. J. 301, 217-223.
33. Kuo Y. M., Emmerling M. R., Vigo-Pelfrey C., Kasunic T. C., Kirkpatrick J. B., Murdoch G. H., Ball M. J., and Roher A. E. (1996) Water-soluble A beta (N-40, N-42) oligomers in normal and Alzheimer disease brains. J. Biol. Chem. 271, 4077-4081.
34. LaDu M. J., Falduto M. T., Manelli A. M., Reardon C. A., Getz G. S., and Frail D. E. (1994) Isoform-specific binding of apolipoprotein E to beta-amyloid. J. Biol. Chem. 269, 23403-23406.
35. Lorenzo A. and Yankner B. (1994) Beta-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. USA 91, 12243-12247.
36. Ma J., Yee A., Brewer H. B., Das S., and Potter H. (1994) Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments [see comments]. Nature 372, 92-94.
37. Maggio J. E., Esler W. P., Stimson E., Jennings J. M., Ghilardi J. R., and Mantyh P. W. (1995) Zinc and Alzheimer's disease. Science 268, 1920-1921.
38. Mantyh P. W., Ghilardi J. R., Rogers S., DeMaster E., Allen C. J., Stimson E. R., and Maggio J. (1993) Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of β-amyloid peptide. J. Neurochem. 61, 1171-1174.
39. Masters C. L., Simms G., Weinman N. A., Multhaup G., McDonald B. L., and Beyreuther K. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82, 4245-4249.
40. Masuoka J., Henegenauer J., Van Dyke B. R., and Saltman P. (1993) Intrinsic stoichiometric equilibrium constants for the binding of zinc (II) and copper (II) to the high affinity site of serum albumin. J. Biol. Chem. 268, 21533-21537.
41. Matsubara E., Frangione B., and Ghiso J. (1995) Characterization of apolipoprotein J-Alzheimer's A beta interaction. J. Biol. Chem. 270, 7563-7567.
42. Mazur-Kolecka B., Frackowiak J., and Wisniewski T. (1995) Apolipoproteins E3 and E4 induce, and transthyretin prevents accumulation of the Alzheimer's beta-amyloid peptide in cultured vascular smooth muscle cells. Brain Res. 698, 217-222.
43. McConnell H. and Bianchine J. (1994) Cerebrospinal Fluid in Neurology and Psychiatry, p. 59. Chapman and Hall, London.
44. Miller D. L., Currie J. R., Iqbal K., Potempska A., and Styles J. (1989) Relationships among the cerebral amyloid peptides and their precursors. Ann. Med. 21, 83-87.
45. Multhaup G., Bush A. I., Pollwein P., and Masters C. L. (1994) Interaction between the zinc (II) and the heparin binding site of the Alzheimer's disease beta A4 amyloid precursor protein (APP). FEBS Lett. 355, 151-154.
46. Okuda R., Uchida K., Tateyama S., Yamaguchi R., Nakayama H., and Goto N. (1994) The distribution of amyloid beta precursor protein in canine brain. Acta Neuropathol. 87, 161-167.
47. Perry G., Siedlak S., Mulvihill P., Kancherla M., Mijares M., Kawai M., Gambetti P., Sharma S., Maggiora L., and Cornette J. (1989) Immunolocalization of the amyloid precursor protein within the senile plaque. Prog. Clin. Biol. Res. 317, 1021-1025.
48. Pike C. J., Walencewicz A. J., Glabe C. G., and Cotman C. W. (1991) In vitro aging of beta-amyloid protein causes peptide aggregation. Brain Res. 563, 311-314.
49. Pike C. J., Burdick D., Walencewicz A. J., Glabe C. G., and Cotman C. W. (1993) Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13, 1676-1687.
50. Pirttilla T., Kim K. S., Mehta P., Frey H., and Wisniewski H. M. (1994) Cerebrospinal fluid concentrations of soluble amyloid beta-protein and apolipoprotein E in patients with Alzheimer's disease: correlations with amyloid load in the brain. J. Neurol. Sci. 127, 90-95.
51. Prelli F., Castano E., Glenner G. G., and Frangione B. (1988) Differences between vascular and plaque core amyloid in Alzheimer's disease. J. Neurochem. 51, 648-651.
52. Roher A. E., Wolfe D., Palutke M., and Kukuruga D. (1986) Purification, ultrastructure, and chemical analysis of Alzheimer disease amyloid plaque core protein. Proc. Natl. Acad. Sci. USA 83, 2662-2666.
53. Roher A. E., Ball M. J., Bhave S.V., and Wakade A. R. (1991) Beta-amyloid from Alzheimer disease brains inhibits sprouting and survival of sympathetic neurons. Biochem. Biophys. Res. Commun. 174, 572-579.
54. Schagger H. and von Jagow G. (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166, 368-379.
55. Schwarzman A. L., Gregori L., Vitek M. P., Lyubski S., Strittmatter W. J., Enghilde J. J., Bhasin R., Silverman J., Weisgraber K. H., Coyle P. K., Zagorski M. G., Talafous J., Eisenberg M., Saunders A. M., Roses A. D., and Goldgaber D. (1994) Transthyretin sequesters amyloid beta protein and prevents amyloid formation. Proc. Natl. Acad. Sci. USA 91, 8368-8372.
56. Segal M. B. (1993) Extracellular and cerebrospinal fluids. J. Inherit. Metab. Dis. 16, 617-638.
57. Selkoe D. J. (1991) The molecular pathology of Alzheimer's disease. Neuron 6, 487-498.
58. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D. L., Shina S., Schlossmacher M., Whaley J., Swindlehurst C., McCormack R., Wolfert R., Bryant K., Lieberburg I., and Schenk D. (1992) Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature 359, 325-327.
59. Shoji M., Golde T. E., Ghiso J., Cheung T. T., Estus S., Shaffer L. N., Cai X. D., McKay D. M., Tintner R., Frangione B., and Younkin S. G. (1992) Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science 258, 126-129.
60. Simmons L. D., May P. C., Tomaselli K. T., Rydel R. E., Fuson K. S., Brigham E. F., Wright S., Lieberburg I., Becher G. W., Brems D. N., and Li W. Y. (1994) Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro. Mol. Pharmacol. 45, 373-379.
61. Snow A. D., Mar H., Noclin D., Sekiguchi R. T., Kimata K., Koike Y., and Wight T. N. (1990) Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. Am. J. Pathol. 137, 1253-1270.
62. Snow A. D., Sekiguchi R., Nochlin D., Fraser P., Kimata K., Mizutani A., Arai M., Schreier W. A., and Morgan D. G. (1994) An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain. Neuron 12, 219-234.
63. Stephenson D. T., Rash K., and Clemens J. (1992) Amyloid precursor protein accumulates in regions of neurodegeneration following focal cerebral ischemia in the rat. Brain Res. 593, 128-135.
64. Strittmatter W. J., Saunders A. M., Schenechel D., Pericak-Vance M., Enghild J., Slavesen G. S., and Roses A. D. (1993a) Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer's disease. Proc. Natl. Acad. Sci. USA 90, 8098-8102.
65. Strittmatter W. J., Huang D. Y., Bhasin R., Roses A. D., and Goldgaber D. (1993b) Avid binding of beta A amyloid peptide to its own precursor. Exp. Neurol. 122, 327-334.
66. Tabaton M., Cammarata S., Mancardi G., Manetto V., Autilio G. L., Perry G., and Gambetti P. (1991) Ultrastructural localization of beta-amyloid, tau, and ubiquitin epitopes in extracellular neurofibrillary tangles. Proc. Natl. Acad. Sci. USA 88, 2098-2102.
67. Tabaton M., Cammarata S., Mandybur T., Richey P., Kawai M., Perry G., and Gambetti P. (1992) Senile plaques in cerebral amyloid angiopathy show accumulation of amyloid precursor protein without cytoskeletal abnormalities. Brain Res. 593, 299-303.
68. Tonder N., Johansen F. F., Frederickson C. J., Zimmer J., and Diemer N. H. (1990) Possible role of zinc in the selective degeneration of hilar neurons after cerebral ischemia in the adult rat. Neurosci. Lett. 109, 247-252.
69. Tully C. L., Snowdon D. A., and Markesbery W. R. (1995) Serum zinc, senile plaques, and neurofibrillary tangles: findings from the Nun study. Neuroreport 6, 2105-2108.
70. Vitek M. P., Bhattacharya K., Glendening J. M., Stopa E., Vlassara H., Bucala R., Manogue K., and Cerami A. (1994) Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc. Natl. Acad. Sci. USA 91, 4766-4770.
71. Wakita H., Tomimoto H., Akiguchi I., Ohnishi K., Nakamura S., and Kimura J. (1992) Regional accumulation of amyloid beta/A4 protein precursor in the gerbil brain following transient cerebral ischemia. Neurosci. Lett. 146, 135-138.
72. Wisniewski T. and Frangione B. (1992) Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135, 235-238.
73. Wood S. J., Chan W., and Wetzel R. (1996a) Seeding of A beta fibril formation is inhibited by all three isotypes of apolipoprotein E. Biochemistry 35, 12623-12628.
74. Wood S. J., Maleef B., Hart T., and Wetzel R. (1996b) Physical, morphological and functional differences between pH 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Aβ. J. Mol. Biol. 256, 870-877.
75. Yankner B. A. (1992) Commentary and perspective on studies of beta amyloid neurotoxicity. Neurobiol. Aging 13, 615-616.
76. Yankner B. A., Duffy L. K., and Kirschner D. A. (1990) Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 250, 279-282.